Ophthalmic Viscoelastic Devices Market Report 2026

Ophthalmic Viscoelastic Devices Market Overview

• Ophthalmic Viscoelastic Devices market size has reached to $2.72 billion in 2025 • Expected to grow to $3.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.1% • Growth Driver: Surging Demand For Ophthalmic Surgeries Driving Growth In The Ophthalmic Viscoelastic Devices Market • Market Trend: Key Players Advancement Revolutionizing Ophthalmic Viscoelastic Devices Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ophthalmic Viscoelastic Devices Market?

An ophthalmic viscoelastic device (OVD) is a gel-like substance that is used during certain types of eye surgery to create and maintain space within the eye, protect delicate intraocular structures, and facilitate surgical maneuvers. OVDs are typically clear, viscous, and elastic, and they are designed to mimic the properties of the natural fluids inside the eye. The main types of ophthalmic viscoelastic devices are cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Cohesive ophthalmic viscoelastic (OVD) refers to a type of viscoelastic substance used during eye surgeries, particularly cataract surgery. Cohesive OVDs are highly viscous and cohesive, and therefore, they tend to stay together as a single mass rather than spreading or dispersing within the eye. These are used in several applications, including cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery, and are used by various end users, such as hospitals, ophthalmology clinics, and others.

What Is The Ophthalmic Viscoelastic Devices Market Growth Forecast?

The ophthalmic viscoelastic devices market size is expected to see strong growth in the next few years. It will grow to $3.47 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to increasing demand for premium ophthalmic surgical outcomes, rising focus on complication reduction, expansion of advanced ophthalmic surgery centers, growing investments in eye care infrastructure, increasing adoption of innovative viscoelastic materials. Major trends in the forecast period include increasing adoption of advanced viscoelastic formulations, rising demand for dual-property ovds, growing focus on enhanced tissue protection, expansion of minimally invasive ophthalmic surgeries, improved shelf stability and biocompatibility profiles.

What Is The Driver Of The Ophthalmic Viscoelastic Devices Market?

The rise in the number of ophthalmic surgeries is expected to propel the growth of the ophthalmic viscoelastic devices market going forward. Ophthalmic surgeries encompass a variety of procedures performed on the eyes, including cataract surgery, corneal transplants, and retinal detachment repair. Ophthalmic viscoelastic devices (OVDs) are used in ophthalmic surgeries to maintain space, protect delicate eye structures, facilitate surgical maneuvers, and ensure clear visualization due to their viscous and elastic properties, aiding in better surgical outcomes and reducing complications such as tissue trauma and intraoperative complications. For instance, in May 2023, according to the National Health Service England, a UK-based publicly funded healthcare system, cataract surgery constitutes 6% of the total surgeries conducted annually, with over 450,000 procedures performed. Projections indicate an estimated 25% increase by 2027 and a staggering 50% surge by 2035 in the number of cataract surgeries. Therefore, the rise in the number of ophthalmic surgeries is driving the growth of the ophthalmic viscoelastic devices industry.

Key Players In The Global Ophthalmic Viscoelastic Devices Market

Major companies operating in the ophthalmic viscoelastic devices market are Altacor Ltd., Bausch Health Companies Inc., Bohus Biotech AB, Carl Zeiss Meditec AG, Haohai Biological Technology Co. Ltd., Johnson & Johnson Pvt. Ltd., Novartis International AG, Rumex International Corporation, Rayner Intraocular Lenses Limited, Aurolab, Alcon Inc., Beaver-Visitec International, Neu Micromed International Pvt. Ltd., Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Croma Pharma GmbH, Medicontur Medical Engineering Ltd., Rhein Medical Inc., MicroSurgical Technology, FCI Ophthalmics Inc., Hanita Lenses Ltd., HOYA Medical Singapore Pte. Ltd.

Global Ophthalmic Viscoelastic Devices Market Trends and Insights

Major companies operating in the ophthalmic viscoelastic devices market are focused on technological advancements, such as line implant-free system solutions, to enhance surgical precision and patient outcomes in eye surgeries. An advanced line implant-free system is a cutting-edge technology that enhances medical procedures without the need for invasive implants, offering non-intrusive solutions for various treatments and interventions. For instance, in April 2023, Bausch + Lomb Corporation, a US-based eye health company, launched the StableVisc cohesive ophthalmic viscosurgical device (OVD) and the TotalVisc Viscoelastic System. StableVisc, a cohesive OVD, helps maintain space in the anterior chamber of the eye to allow surgeons to extract and replace the clouded natural lens. The TotalVisc Viscoelastic System includes both StableVisc and ClearVisc, a dispersive OVD, and protects ocular tissue during the surgical procedure. These products contain sodium hyaluronate and sorbitol, a unique chemical compound that, when compared to other OVDs examined in laboratory research, has been found to deliver improved free radical scavenging properties. Dual-action mechanical and chemical protection is offered by TotalVisc OVD.

What Are Latest Mergers And Acquisitions In The Ophthalmic Viscoelastic Devices Market?

In January 2024, Nordic Group B.V, the Netherlands-based pharmaceutical company, acquired Visant Medical, Inc for an undisclosed amount. The acquisition enables Nordic Group B.V to strengthen its global ophthalmology market portfolio, and expand its commercialization and development of specialty products in therapeutics areas covering ophthalmology range. Visant Medical, Inc is a US-based medical device company that specializes in developing innovative medical devices for ophthalmic applications.

What Defines the Ophthalmic Viscoelastic Devices Market?

The ophthalmic viscoelastic devices market consists of sales of cohesive OVDs, dispersive OVDs, and combined OVDs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ophthalmic Viscoelastic Devices Market Report 2026?

The ophthalmic viscoelastic devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic viscoelastic devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.